Advertisement

Vascular Brachytherapy

  • Boris Pokrajac
  • Erich Minar
  • Christian Kirisits
  • Richard Pötter
Part of the Medical Radiology book series (MEDRAD)

Keywords

Radiat Oncol Biol Phys Critical Limb Ischemia Restenosis Rate Femoropopliteal Artery Binary Restenosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Böttcher HD, Schopohl B, Liermann D, Kollath J, Adamietz IA (1994) Endovascular irradiation — a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results. Int J Radiat Oncol Biol Phys 29:183–186PubMedGoogle Scholar
  2. Condado JA, Waksman R, Gurdiel O et al. (1997) Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 96:727–732PubMedGoogle Scholar
  3. Costa MA, Sabate M, van der Giessen WJ et al. (1999) Late coronary occlusion after intracoronary brachytherapy. Circulation 100:789–792PubMedGoogle Scholar
  4. Duda SH, Pusich B, Richter G et al. (2002) Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106:1505–1509PubMedCrossRefGoogle Scholar
  5. Greiner RH, Mahler F, Jäger K, Schneider E, Gallino A (2003) Swiss trials of peripheral endovascular brachytherapy for restenosis prevention after PTA. Radiother Oncol 66(Suppl 1):S6 (Abstract)Google Scholar
  6. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, Wong SC, Fish D, Ellis S, Holmes DR, Keriakes D, Kuntz RE (2001) Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 344:250–256PubMedCrossRefGoogle Scholar
  7. King SB, Williams DO, Chougule P et al. (1998) Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty. Results of the Beta Energy Restenosis Trial (BERT). Circulation 97:2025–2030PubMedGoogle Scholar
  8. Kirisits C, Georg D, Wexberg P et al. (2002) Determination and application of the reference isodose length (RIL) for commercial endovascular brachytherapy devices. Radiother Oncol 64:309–315PubMedCrossRefGoogle Scholar
  9. Kuntz RE, Baim DS (1993) Defining coronary restenosis: newer clinical and angiographic paradigms. Circulation 88:1310–1323PubMedGoogle Scholar
  10. Minar E, Pokrajac B, Ahmadi R et al. (1998) Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. Radiology 208:173–179PubMedGoogle Scholar
  11. Minar E, Pokrajac B, Maca T et al. (2000a) Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective, randomized study. Circulation 102:2694–2699PubMedGoogle Scholar
  12. Minar E, Wolfram R, Pokrajac B (2000b) Endovascular brachytherapy and late thombotic occlusion. Circulation 102:el175–el176Google Scholar
  13. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R, RAVEL Study Group (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780PubMedCrossRefGoogle Scholar
  14. Pokrajac B, Pötter R, Maca T, Fellner C, Mittlböck M, Ahmadi R, Seitz W, Minar E (2000) Intra-arterial 192Ir HDR brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2 trial radiotherapy parameters and risk factors analysis. Int J Radiat Oncol Biol Phys 48:923–931PubMedCrossRefGoogle Scholar
  15. Pokrajac B, Cejna M, Kettenbach J et al. (2001) Intraluminal 192Ir brachytherapy following transjugular intrahepatic portosystemic shunt revision: long terms results and radiotherapy parameters. Cardiovasc Radiat Med 2:133–137PubMedCrossRefGoogle Scholar
  16. Pokrajac B, Schmid R, Pötter R, Wolfram R, Kirisits C, Mendel H, Kopp M, Minar E (2003) Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 multicenter study. Int J Radiat Oncol Biol Phys 57(Suppl 2):S250 (Abstract)Google Scholar
  17. Popowski Y, Verin V, Urban P (1996) Endovascular ß-radiation after percutaneous transluminal coronary balloon angio-plasty. Int J Radiat Oncol Biol Phys 36:841–845PubMedGoogle Scholar
  18. Pötter R, Van Limbergen E (2002) Endovascular brachytherapy: In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E (eds) The GEC ESTRO handbook of brachytherapy. ACCO, Leuven, BelgiumGoogle Scholar
  19. Pötter R, Van Limbergen E, Dries W, Popowski Y, Coen V, Fellner C, Georg D, Kirisits C, Levendag P, Marijnissen H, Marsiglia H, Mazeron JJ, Pokrajac B, Scalliet P, Tamburini V, EVA GEC ESTRO Working Group (2001) Recommendations for prescribing, recording, and reporting endovascular brachytherapy. Radiother Oncol 59:339–360PubMedGoogle Scholar
  20. Rubin P, Williams JP, Riggs PN et al. (1998) Cellular and molecular mechanisms of radiation inhibition of restenosis. Part I. Role of the macrophage and platelet-derived growth factor. Int J Radiat Oncol Biol Phys 40:929–941PubMedCrossRefGoogle Scholar
  21. Schmid R, Kirisits C, Syeda B et al. (2004) Evaluation of geographic miss in endovascular brachytherapy of the coronaries. A new method of assessment. Recommendations for determining the planning target length to avoid geographic miss. The Vienna experience.(Evaluation of geographic miss in endovascular brachytherapy). Radiother Oncol 71(3):311–8PubMedCrossRefGoogle Scholar
  22. Schopohl B, Liermann D, Jülling-Pohlit L et al. (1996) 192 Ir endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels. Six years of experience. Int J Radiat Oncol Biol Phys 36:835–840PubMedCrossRefGoogle Scholar
  23. Stoeteknuel-Friedli S, Do DD, Briel C von et al. (2002) Endovascular brachytherapy for prevention of recurrent renal in-stent restenosis. J Endovasc Ther 9:350–353PubMedCrossRefGoogle Scholar
  24. Suntharalingam M, Laskey W, Lansky AJ et al. (2002) Clinical and angiographic outcomes after use of strontium-90/yttrium-90 beta radiation for the treatment of in-stent restenosis: results from the stents and radiation therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys 52:1075–1082PubMedCrossRefGoogle Scholar
  25. Tardif JC, Cote G, Lesperance J et al. (1997) Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 337:365–372PubMedCrossRefGoogle Scholar
  26. Teirstein P (2000) Fulfilling the promises of percutaneous angioplasty. Circulation 102:2674–2676PubMedGoogle Scholar
  27. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Morris NB, Leon MB, Tripuraneni P (1997) Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 336:1697–1703PubMedCrossRefGoogle Scholar
  28. Teirstein PS, Massullo V, Jani S et al. (2000) Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 101:360–365PubMedGoogle Scholar
  29. Verin V, Popowski Y, de Bruyne B, Baumgart D, Sauerwein W, Lins M, Kovacs G, Thomas M, Calman F, Disco C, Serruys PW, Wijns W (2001) Dose-Finding Study Group. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. N Engl J Med 344:243–249PubMedCrossRefGoogle Scholar
  30. Waksman R, Laird JR, Jurkovitz CT et al. (2001) Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the Paris feasibility clinical trial. J Vasc Interv Radiol 12:915–921PubMedGoogle Scholar
  31. Waksman R, Raizner AE, Yeung AC et al. (2002) Use of localized intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomized controlled trial. Lancet 359:551–557PubMedCrossRefGoogle Scholar
  32. Waksman R, Ajani AE, White RL et al. (2004) Five-year follow-up after intracoronary gamma radiation therapy for instent restenosis. Circulation 109:340–344PubMedCrossRefGoogle Scholar
  33. Weintraub WS, and the LRT Study Group (1994) Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 331:1331–1337PubMedCrossRefGoogle Scholar
  34. Wiedermann JG, Marboe C, Schwartz A (1994) Intracoronary irradiation reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol 23:1491–1498PubMedCrossRefGoogle Scholar
  35. Wolfram R, Pokrajac B, Ahmadi R et al. (2001) Endovascular brachytherapy for prophylaxis of restenosis after longsegment femoropopliteal stenting: pilot study. Radiology 220:724–729PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • Boris Pokrajac
    • 1
  • Erich Minar
    • 2
  • Christian Kirisits
    • 1
  • Richard Pötter
    • 1
  1. 1.Department of Radiotherapy and Radiobiology, Vienna General HospitalMedical University of ViennaViennaAustria
  2. 2.Department of Angiology, Vienna General HospitalMedical University of ViennaViennaAustria

Personalised recommendations